Director, Global Regulatory Policy
Julie is a regulatory affairs professional specialising in international regulatory policy with impact to innovative medicines. She focuses on advancing science-based regulatory policy, including in the area of global regulatory system strengthening. In her role, she implements strategic regulatory policy initiatives and develops recommendations to address regional regulatory policy challenges. She has over seventeen years industry experience and is a member of the International Regulatory Expert Group of the European Federation of Pharmaceutical Industries and Association (EFPIA).